Sonablate

Sonablate®

Urology A device that uses high-intensity focused ultrasound–HIFU technology, combining focused ultrasound beams and imaging, to heat and destroy targeted tissue without affecting surrounding healthy tissue Indications Treatment of BPH. See Benign prostatic hypertrophy.
Mentioned in ?
References in periodicals archive ?
On October 2015, the company received the US FDA clearance for Sonablate, since then more than 1,200 patients have had a Sonablate HIFU prostate procedure across the more than 40 locations in the US, including placements at top-tier academic institutions in California, Indiana, Oklahoma, Maryland, New York, Arizona as well as Texas.
SonaCare Medical reports growth in ASC payment for HIFU device-intensive procedure in prostate ablation
Two HIFU technologies, the Ablatherm and the Sonablate, were available at the moment of treatment of the patient.
Levator Ani Necrosis: An Exceptional Complication Occurring after "High Intensity Focused Ultrasound" of the Prostate
HIFU treatment was performed using the Sonablate 500 machine (SonaCare Medical, Charlotte, NC).
Comparative morbidity of ablative energy-based salvage treatments for radio-recurrent prostate cancer
The developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions said it has introduced its Sonablate 500 for prostate cancer into the European market.
Misonix Inc. (Nasdaq) led advancing issues, surging $1.25, or 29% on the week, to $5.60
Misonix develops, manufactures, and markets medical, scientific and industrial ultrasonic and air pollution systems and maintains a minority equity position in Focus Surgery as its exclusive manufacturer of the Sonablate 500.
Misonix's Sonora medical unit receives ultrasound patent
Focus Surgery entered into an exclusive International Distribution Agreement, outside of Asia and the United States, with Endocare Corporation for its Sonablate 500 unit, which treats prostate cancer and Benign Prostatic Hyperplasia (BPH) using High Intensity Focused Ultrasound, (HIFU).
MISONIX REPORTS LOWER REVENUES FOR FISCAL 2002
The FDA has approved for market in the United States the Sonablate for the ablation of prostate tissue and the treatment is now available in the US, US-based prostate cancer treatment provider HIFU Prostate Services said.
With FDA Clearance, Minimally Invasive Prostate Cancer Treatment Now Available in US
Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer.
Salvage radiotherapy after high-intensity focused ultrasound treatment for localized prostate cancer: feasibility, tolerance and efficacy
The Sonablate HIFU devices will be delivered to San Francisco Surgery Center and First Urology this week and the first patients are scheduled for HIFU treatment in Louisville with Jurige.
New Partnership Aims for Commercial Launch of Minimally Invasive Prostate Treatment in the US
22] and "HIFU using the Sonablate 500 carries little risk of side effects like impotence and incontinence.
HIFU ablation is not a proven standard treatment for localized prostate cancer
US-based HIFU Prostate Services, LLC, a provider of minimally-invasive prostate cancer treatments using high intensity focused ultrasound, has launched operations and placed an initial purchase order of five Sonablate systems from HIFU technology provider SonaCare Medical, LLC, the company said.
Minimally-Invasive Prostate Cancer Treatment Specialist Launches Operations
The patient was treated with salvage high-intensity focused ultrasound (HIFU) as part of a phase II trial, using the Sonablate 500 Console (Focus Surgery, Inc.
Histological changes in the human prostate after radiotherapy and salvage high intensity focused ultrasound

Medical browser ?
Full browser ?